Mantle Cell Lymphoma: The Far-Far Away Treatment Results in a Public Hospital In Brazil
Growing understand Mantle Cell (MCL) Lymphoma pathogenesis develop new drugs and increase its overall survival. We do not observe this increasing in Brazil ’s public health system because no access to these drugs.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Sergio Brasil, Carolina Cola ço, Cristina Bortolheiro, Tomas Barrese, Renata Bacic, Roberto Paes, Rodolfo Cancado Source Type: research
More News: Brazil Health | Hospitals | International Medicine & Public Health | Leukemia | Lymphoma | Myeloma